Log In
Print
BCIQ
Print
Print this Print this
 

ALLN-177

  Manage Alerts
Collapse Summary General Information
Company Allena Pharmaceuticals Inc.
DescriptionOral oxalate degrading enzyme
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationHyperoxaluria
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today